+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 64Years
All Genders
ID07857941

Novel Treatments for Gut-Liver-Brain Disorders Effects on Digestive and Psychological Symptoms and Pathology

Led by Buddhist Tzu Chi General Hospital · Updated on 2026-10-05

45

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Functional dyspepsia FD involves inflammatory responses triggered by histamine release from eosinophils and mast cells, leading to increased intestinal mucosal permeability. This permeability is a key factor in FD development. Researchers are exploring the effects of combining H1 and H2 antihistamine antagonists compared to using only H1 antagonists, as current evidence shows both types can be effective but have not been directly compared. The study also considers the overlap of fatty liver disease and irritable bowel syndrome IBS which share common factors and may worsen symptoms and quality of life. Participants are divided into groups to receive different treatments one group takes famotidine an H2 antagonist plus levocetirizine an H1 antagonist, another group takes only levocetirizine, and a control group receives placebo. Medications are given at specified doses and times, such as famotidine 20mg twice daily and levocetirizine 5mg once before bed. Some groups also receive Fuyuan Gasmin tablets to help reduce gastrointestinal gas. This phase 2 randomized trial runs for 84 days, assessing the impact of these therapies on symptoms and underlying physiological changes. During the study, participants undergo evaluations at baseline and day 84, which include symptom scales for functional dyspepsia, gastrointestinal pain, sleep quality, depression, anxiety, stress, and visceral sensitivity. Researchers monitor changes in these scores to assess treatment effects. Participants are monitored for adherence and safety throughout the trial. The total study duration is about 12 weeks, with regular assessments to track progress and any side effects.

CONDITIONS

Brief Title

Exploring Novel Therapeutic Approaches for Disorders of Gut-Liver-Brain Interaction-H1/H2

Research Team

M

Ming-Wun Wong

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here